Amgen (AMGN) PT Raised to $332 at Morgan Stanley
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $437.79 +0.94%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Morgan Stanley analyst Terance Flynn raised the price target on Amgen (NASDAQ: AMGN) to $332.00 (from $326.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- Amgen (AMGN) PT Raised to $352 at Mizuho
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
